This was the last item I posted on the blog Nov 6 before we took it down a few days later to start the overhaul. In case you didn’t get a chance to read it, I’m reprinting it.
She was a saleswoman prone to bipolar mood swings, stable on a brand name prescription mood stabilizer. It had originally been marketed as an anticonvulsant and her medication was doing its job. She recently returned to full-time work after a manic attack had cost her both her marriage and the custody of her child.
“I don’t have the insurance I once did; I now sell home decoration instead of heating fuel like I used to. The money is better, but now all of a sudden the cost of my medication is really ridiculous. The generic is lots cheaper.”